1-119750831-G-A
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PM5PP3_Strong
The NM_005518.4(HMGCS2):c.1498C>T(p.Arg500Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000186 in 1,613,780 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R500H) has been classified as Pathogenic.
Frequency
Consequence
NM_005518.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HMGCS2 | NM_005518.4 | c.1498C>T | p.Arg500Cys | missense_variant | 9/10 | ENST00000369406.8 | NP_005509.1 | |
HMGCS2 | NM_001166107.1 | c.1372C>T | p.Arg458Cys | missense_variant | 8/9 | NP_001159579.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HMGCS2 | ENST00000369406.8 | c.1498C>T | p.Arg500Cys | missense_variant | 9/10 | 1 | NM_005518.4 | ENSP00000358414 | P1 | |
HMGCS2 | ENST00000544913.2 | c.1372C>T | p.Arg458Cys | missense_variant | 8/9 | 2 | ENSP00000439495 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152134Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251332Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135834
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1461646Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 14AN XY: 727130
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152134Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74320
ClinVar
Submissions by phenotype
3-hydroxy-3-methylglutaryl-CoA synthase deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 500 of the HMGCS2 protein (p.Arg500Cys). This variant is present in population databases (rs756539895, gnomAD 0.003%). This missense change has been observed in individual(s) with 3-hydroxy-3-methylglutaryl-CoA synthase deficiency (PMID: 32952630). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on HMGCS2 protein function. Experimental studies have shown that this missense change affects HMGCS2 function (PMID: 32952630). This variant disrupts the p.Arg500 amino acid residue in HMGCS2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 11479731, 23751782, 32952630). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at